Supporting Quality Life
We are working to provide the ounce of prevention.
Welcome to H&G Science, Inc., the advanced Biotechnology Manufacturing, Research and Development team paving the way to the future. We believe that our sophisticated technology has the potential to revolutionize the cancer therapeutic market.
About Us
H&G Science has over 20 years of experience in extracting tocotrienols, at high purity, from natural red palm sources.
We have proposals on hand to initiate several clinical trials on the use of our tocotrienols to treat cancer and protect against cancer causing radiation exposure.
Our expanding portfolio of intellectual property covers novel formulation, administration, and semi-synthetic applications, as well as commercial extraction and manufacturing approaches.
Our Story
H&G Science’s mission is to provide safer and more effective treatments for cancer and other diseases using sustainable naturally derived products. Our current primary focus is the use of tocotrienols to prevent and treat cancer and other diseases. Tocotrienols, which received GRAS (Generally Recognized As Safe) status from the FDA, are most easily obtained from the naturally occurring red palm fruit. They have been indicated as anti-cancer agents, radiation protecting agents, and preventive agents against many diseases and ailments. H&G Science is positioned to be the first and only supplier of the highly-purified tocotrienol products needed to enter this exciting new market.
The Opportunity
We are actively looking for capital partners to help us flourish. We are uniquely positioned to grow at an unprecedented rate by expanding our research capabilities, market footprint and partnership networks.
Let’s work together.
Our Partners
The Team at HG Semmelweis are developing products and distribution methods to help people find the best way to keep themselves healthy, during the current pandemic, by fighting and possibly preventing the deadly COVID-19 virus and its damaging symptoms.
Leadership Team
Ed Glicken - CEO
Ed has a formal background as an attorney and for nearly 25 years, he has headed operations and business development as CEO, President and VP of Operations at biotechnology companies. He is actively involved in relationships with key researchers and practitioners in natural cancer therapy development.
Kevin Henretta - CTO
Kevin has a formal background in chemistry, 20 years of experience as a commercial scale drug production equipment Design Engineer, and 20 years of experience developing large-scale purification and extraction technologies. Kevin is a leading expert on tocotrienol extraction and purification, as well as other natural and synthetic product purification techniques.